Danaher Corp (NY:DHR)

232.31 +7.62 (+3.39%)

Delayed Quote Updated: 3:02 PM EDT, Oct 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Danaher Corp

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

29 30 Next >

Looking Into Danaher's Recent Short Interest ↗

March 25, 2025

Via Benzinga

Movers and shakers in today's after-hours session for S&P500 stocks? ↗

March 24, 2025

The US market session of Monday is over, let's have a look at the top S&P500 gainers and losers in the after hours session today.

Via Chartmill

Behind the Scenes of Danaher's Latest Options Trends ↗

March 24, 2025

Via Benzinga

Check Out What Whales Are Doing With DHR ↗

March 21, 2025

Via Benzinga

Research Tools & Consumables Stocks Q4 Recap: Benchmarking Waters Corporation (NYSE:WAT)

March 20, 2025

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the research tools & consumables industry, including Waters Corporation (NYSE:WAT) and its peers.

Via StockStory

Topics Economy

If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today ↗

February 26, 2025

Via Benzinga

Danaher's Options Frenzy: What You Need to Know ↗

February 21, 2025

Via Benzinga

P/E Ratio Insights for Danaher ↗

February 20, 2025

Via Benzinga

Unpacking the Latest Options Trading Trends in Danaher ↗

March 14, 2025

Via Benzinga

Forecasting The Future: 10 Analyst Projections For Danaher ↗

March 14, 2025

Via Benzinga

Research Tools & Consumables Stocks Q4 Recap: Benchmarking Bruker (NASDAQ:BRKR)

March 12, 2025

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including Bruker (NASDAQ:BRKR) and its peers.

Via StockStory

Topics Economy

Danaher (DHR): Buy, Sell, or Hold Post Q4 Earnings?

March 11, 2025

Shareholders of Danaher would probably like to forget the past six months even happened. The stock dropped 23.9% and now trades at $207. This might have investors contemplating their next move.

Via StockStory

Q4 Earnings Highlights: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks

March 05, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Thermo Fisher (NYSE:TMO) and its peers.

Via StockStory

Topics Economy

Danaher's Options Frenzy: What You Need to Know ↗

February 12, 2025

Via Benzinga

Danaher Unusual Options Activity For February 07 ↗

February 07, 2025

Via Benzinga

Danaher's Options: A Look at What the Big Money is Thinking ↗

February 03, 2025

Via Benzinga

Unpacking Q4 Earnings: Danaher (NYSE:DHR) In The Context Of Other Research Tools & Consumables Stocks

March 04, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Danaher (NYSE:DHR) and the best and worst...

Via StockStory

Topics Economy

Dan Loeb Adjusts Healthcare Holdings: Danaher Stake Trimmed As Thermo Fisher Gains Favor ↗

February 25, 2025

Loeb's Third Point LLC restructured their portfolio in last quarter of 2024. They decreased stake in Danaher Corp. and acquired stake in Thermo Fisher.

Via Benzinga

3 Stocks Offering Strong Value and Stability

February 24, 2025

These stocks may be undervalued based on recent price activity, new partnerships, or disappointing earnings that mask strong underlying performance.

Via MarketBeat

Repligen Q4 Earnings Momentum Highlights Market Growth, Issues Strong 2025 Outlook ↗

February 20, 2025

Repligen reported Q4 EPS of $0.44, beating estimates, with revenue of $167.55 million. The company projects 2025 sales of up to $710 million as the market recovers.

Via Benzinga

Here's How Much You Would Have Made Owning Danaher Stock In The Last 10 Years ↗

January 30, 2025

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

February 18, 2025

Via Benzinga

Super Investors Just Bought These Stocks ↗

February 18, 2025

Every quarter, we get to see what the best of the best have bought and sold.

Via The Motley Fool

3 Healthcare Stocks Skating on Thin Ice

February 12, 2025

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But near-term speed bumps have persisted in the wake of COVID-19 as players destocked inventories in 2023 and...

Via StockStory

Topics Stocks

Waters Corporation Earnings: What To Look For From WAT

February 11, 2025

Scientific instruments company Waters Corporation (NYSE:WAT) will be reporting earnings tomorrow before the bell. Here’s what to look for.

Via StockStory

Jim Cramer Likes This Utilities Stock: 'I Think You've Got A Good One' ↗

February 07, 2025

NextEra Energy posted in-line earnings for the fourth quarter and said it continues to expect adjusted EPS of $3.45-$3.70 for fiscal 2025.

Via Benzinga

Avantor Earnings: What To Look For From AVTR

February 06, 2025

Life sciences company Avantor (NYSE:AVTR) will be reporting earnings tomorrow before market hours. Here’s what you need to know.

Via StockStory

Earnings To Watch: Mettler-Toledo (MTD) Reports Q4 Results Tomorrow

February 05, 2025

Precision measurement company Mettler-Toledo (NYSE:MTD) will be announcing earnings results tomorrow after market close. Here’s what to expect.

Via StockStory

This FedEx Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday ↗

February 03, 2025

Via Benzinga

Danaher’s (NYSE:DHR) Q4 Sales Beat Estimates

January 31, 2025

Diversified science and technology company Danaher (NYSE:DHR) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 2.1% year on year to $6.54 billion. Its non-GAAP profit of $2.14 per...

Via StockStory

Topics Earnings

< Previous 1 2

...

6 7 8 9 10 11 12 13 14

...

29 30 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.